---
title: "Capital Securities aims to become the 14th \"A+H\" listed brokerage firm approved by the China Securities Regulatory Commission"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283238327.md"
description: "On April 17th, the International Cooperation Department of the China Securities Regulatory Commission issued the \"Notice on the Filing of Overseas Issuance and Listing by Capital Securities Co., Ltd.\", confirming the overseas issuance and listing filing information of Capital Securities Co., Ltd. (hereinafter referred to as \"Capital Securities\", 601136). The filing notice shows that Capital Securities plans to issue no more than 1.048 billion overseas listed ordinary shares and list them on the Hong Kong Stock Exchange. (The Paper)"
datetime: "2026-04-19T02:15:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283238327.md)
  - [en](https://longbridge.com/en/news/283238327.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283238327.md)
---

# Capital Securities aims to become the 14th "A+H" listed brokerage firm approved by the China Securities Regulatory Commission

On April 17th, the International Cooperation Department of the China Securities Regulatory Commission issued the "Notice on the Filing of Overseas Issuance and Listing by Capital Securities Co., Ltd.", confirming the overseas issuance and listing filing information of Capital Securities Co., Ltd. (hereinafter referred to as "Capital Securities", 601136). The filing notice shows that Capital Securities plans to issue no more than 1.048 billion overseas listed ordinary shares and list them on the Hong Kong Stock Exchange. (The Paper)

### Related Stocks

- [601136.CN](https://longbridge.com/en/quote/601136.CN.md)
- [25281.HK](https://longbridge.com/en/quote/25281.HK.md)

## Related News & Research

- [Bermoxel® (Praziquantel 600 mg) Now Available Across All 27 EU Member States Amid Restricted Biltricide® Availability](https://longbridge.com/en/news/296131355.md)
- [Optomed Oyj (HEL:OPTOMED) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/296297835.md)
- [XSpray Pharma receives FDA complete response letter for Dasynoc over GMP issues at contract manufacturer](https://longbridge.com/en/news/296285939.md)
- [MTN Rwanda releases H1 2026 results on Rwanda Stock Exchange](https://longbridge.com/en/news/296245062.md)
- [Wispr Flow valued at $2 billion in latest funding round](https://longbridge.com/en/news/296115555.md)